MedTrace Logo

Substrate Ablation Guided by High Density Mapping in Atrial Fibrillation

NCT02093949 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2017-11-06

Study results available
· View outcomes & findings →

Summary

To evaluate a new AF Substrate mapping method based on automatic high density CFAE detection with a multipolar catheter (Pentaray) and the " SCI 30-40 " setting of CARTO CFAE algorithm.

Conditions

Interventions

PROCEDURE

Routine substrate ablation without pulmonary vein Isolation

PROCEDURE

Routine conventional ablation with pulmonary vein Isolation

Sponsors & Collaborators

  • Hospital St. Joseph, Marseille, France

    lead OTHER

Principal Investigators

  • Julien Seitz, MD · St Joseph hospital Marseille

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-12-31
Completion
2016-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02093949 on ClinicalTrials.gov